ArticleAnnals of nuclear medicine2026

Comment on "Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study".

Kotina Shridevi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.